한글목차

PCOS 진단 시장은 2025년에는 39억 달러로 추정되고, 2032년에는 54억 9,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 5%를 나타낼 전망입니다.

PCOS는 출산 적령기 여성의 10명 중 1명이 앓고 있는 호르몬 질환입니다. 생리 불순, 임신하기 어려운 체질, 얼굴이나 몸의 발모의 원인이 됩니다. 이 질환은 월경 불순, 배란 이상, 높은 안드로겐 수치, 난소 비대, 인슐린 저항성 등을 유발합니다. 전 세계에서 500만 명의 생식 연령의 여성이 병을 앓고 있는 것으로 밝혀졌습니다. 또한 불임, 류마티스 관절염, 고혈압, 심장병, 당뇨병 등 심각한 합병증을 유발합니다.

시장 역학 :

PCOS 증례 급증, PCOS 유병률 증가, PCOS 증상에 대한 여성 의식 증가가 예측 기간 동안 세계의 PCOS 진단 시장 성장을 가속할 것으로 전망됩니다.

그러나 PCOS 질환 치료제의 규제 당국에 의한 엄격한 승인 과정과 치료제의 부작용이 예측 기간 동안 세계의 PCOS 진단 시장 성장을 방해할 것으로 전망됩니다.

예를 들어, 2023년 6월 28일, 세계보건기구(WHO)가 제공한 데이터에 따르면, PCOS는 공중위생상의 중요한 문제이며, 생식연령의 여성에 영향을 미치는 가장 흔한 호르몬 장애 중 하나입니다. 여성의 8-13%가 영향을 받는 것으로 추정되고, 세계 최대 70%의 증례가 진단되지 않았습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 PCOS 진단 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
• 다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
• 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 PCOS 진단 시장 주요 기업 프로파일을 제공합니다.
• 이 보고서로부터의 인사이트은 마케팅 담당자나 기업의 경영진이, 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 할 것입니다.
• 세계의 PCOS 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 PCOS 진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 맵(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• PCOS의 유병률 증가
• 의식의 고조와 조기 진단
• 진단에 있어서의 기술의 진보
• 헬스케어비 증가
  • 성장 억제요인
• 표준화된 진단 기준의 부족
• 인식 부족과 진단 부족
• 비용과 저렴한 가격
  • 기회
• 다낭성 난소 증후군의 치료에 대한 의식 증가
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 PCOS 진단 시장 - 코로나 바이러스(COVID-19) 유행의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 PCOS 진단 시장, 진단 검사 유형별(2020-2032년)

• 호르몬 검사
• 화상 검사
• 혈액검사
• 골반 검사
• 유전자 검사
• 기타 검사

제6장 PCOS 진단 시장, 최종 사용자별(2020-2032년)

• 병원 및 진료소
• 불임 치료 클리닉
• 재택 케어 환경
• 진단 실험실

제7장 PCOS 진단 시장, 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙아프리카

제8장 경쟁 구도

• Hoffmann-La Roche Ltd
• Abbott
• Quest Diagnostics
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Bio-Rad Laboratories
• Hologic, Inc.
• Vitrolife
• Myriad Genetics, Inc.
• Ansh Labs
• Diagnostica Stago Inc.
• Beckman Coulter, Inc.
• Randox Laboratories Ltd.
• GE Healthcare
• PrivaPath Diagnostics
• Laboratory Corporation of America Holdings
• SRL Diagnostics

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Pcos Diagnostic Market is estimated to be valued at USD 3.9 Bn in 2025 and is expected to reach USD 5.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age globally. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.

Market Dynamics:

Surging cases of the PCOS condition, increasing prevalence of PCOS, and increased awareness among women about its symptoms are expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors, including obesity, a sedentary lifestyle, and hormonal disorders, are also expected to drive the market's growth.

However, stringent regulatory approval processes for PCOS disease drugs and the side effects of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.

For instance, on June 28, 2023, according to data provided by the World Health Organization, PCOS a significant public health problem and is one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age, and up to 70% of cases are undiagnosed worldwide. The prevalence of PCOS is higher among some ethnicities, and these groups often experience more complications, as in particular those related to metabolic problems.

Key features of the study:

• This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global PCOS diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market

Detailed Segmentation:

• PCOS Diagnostic Market, By Type of Diagnostic Test:
  • Hormone Test
  • Imaging Tests
  • Blood Tests
  • Pelvic Examination
  • Genetic Testing
  • Other Tests
• PCOS Diagnostic Market, By End User:
  • Hospitals and Clinics
  • Fertility Clinics
  • Homecare Settings
  • Diagnostic Laboratories
• PCOS Diagnostic Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Hologic, Inc.
  • Vitrolife
  • Myriad Genetics, Inc.
  • Ansh Labs
  • Diagnostica Stago Inc.
  • Beckman Coulter, Inc.
  • Randox Laboratories Ltd.
  • GE Healthcare
  • PrivaPath Diagnostics
  • Laboratory Corporation of America Holdings
  • SRL Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market PCOS Diagnostic, By Type of Diagnostic Test
  • Market PCOS Diagnostic, By End User
  • Market PCOS Diagnostic, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of PCOS
• Growing Awareness and Early Diagnosis
• Technological Advancements in Diagnostics
• Rising Healthcare Expenditure
  • Restraints
• Lack of Standardized Diagnostic Criteria
• Limited Awareness and under diagnosis
• Cost and Affordability
  • Opportunities
• Growing awareness about polycystic ovarian syndrome treatment
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. PCOS Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. PCOS Diagnostic Market, By Type of Diagnostic Test, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hormone Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Imaging Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Blood Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pelvic Examination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. PCOS Diagnostic Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. PCOS Diagnostic Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vitrolife
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Myriad Genetics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ansh Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Diagnostica Stago Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Beckman Coulter, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Randox Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PrivaPath Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Laboratory Corporation of America Holdings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• SRL Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us